...
机译:大肠杆菌允许将新分离的Quinomycin生物合成酶有效地模块化整合到Echinomycin生物合成途径中,以有效设计和合成有效的抗生素非天然天然产物
Research Core for Interdisciplinary Sciences, Okayama University, Okayama 700-8530, Japan;
Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore;
Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo 060-0810, Japan;
BioPharmaceuticals Formulation Development, Allergan, Inc., 2525 Dupont Drive, Irvine, California 92612;
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90033;
Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo 060-0810, Japan;
Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan;
The Analytical Core facility of NMR and Mass spectrometry, School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan;
Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore Creative Research Initiative 'Sousei' (CRIS), Hokkaido University, Sapporo 001-0021, Japan;
Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo 060-0810, Japan;
机译:利用大肠杆菌中植物的生物合成途径合成非天然类黄酮和芪类化合物
机译:大肠杆菌中天然奎诺霉素二肽的合成类似物的合理设计的总生物合成
机译:CYS115表征大肠埃希氏菌细胞壁生物合成酶UDP-GLCNAC烯丙基戊二酸转移酶(MURA)中ASP的取代,这种抗微生物剂能使抗菌素福美辛活化
机译:生物材料设计:在大肠杆菌中创建新型正交翻译系统,用于脯氨酸类似物在生物合成蛋白材料中的位点特异性整合
机译:大肠杆菌允许有效地将新分离的醋霉素生物合成酶结合到Echinomycin生物合成途径用于合理的设计和合成有效的抗生素非自然产品
机译:利用大肠杆菌中植物的生物合成途径合成非天然类黄酮和对苯二酚